Sebetralstat bulk supplier for pharma manufacturers

Sebetralstat 300mg Suppliers & Bulk Manufacturers

Available Forms: Tablets

Available Strengths: 300mg

Reference Brands: Ekterly (USA)

Sebetralstat is an oral plasma kallikrein inhibitor used for the on-demand treatment of hereditary angioedema (HAE) attacks in adults and adolescents. It reduces bradykinin production, which helps control swelling episodes caused by HAE.

Get Enquiry / Request Bulk Quote

Quick Response Guaranteed | Verified Suppliers

Sebetralstat — third party manufacturing & bulk supply

Sebetralstat 300mg is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:

Wholesale / bulk supply Stock or scheduled supply from an existing manufacturer. The fastest route where the product is already registered in your market.

Third party manufacturing Manufactured to your specification and packed under your own brand and label — suits distributors and brand owners building a portfolio in their market.

Dossier licensing Where a CTD, EU-CTD or ACTD dossier exists it can often be licensed for filing in your name, compressing market entry from years to months.

Indicative minimum order quantity

Sebetralstat is supplied as Tablets — an oral solid dosage form, so the indicative MOQ is 200,000 units. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.

Manufacturers of Sebetralstat listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding.

Request a quote for Sebetralstat →

Back to Listing

Frequently Asked Questions

Sebetralstat is listed as Tablets in 300mg. Further strengths and pack presentations are confirmed with the manufacturer at RFQ stage.

Sebetralstat is referenced against Ekterly (USA). Reference brands are shown for identification only and remain the property of their respective trademark owners.